Spread of pathology in amyotrophic lateral sclerosis: assessment of phosphorylated TDP-43 along axonal pathways
Open Access
- 28 July 2015
- journal article
- research article
- Published by Springer Nature in Acta Neuropathologica Communications
- Vol. 3 (1) , 1-9
Abstract
The progression of amyotrophic lateral sclerosis (ALS) through the brain has recently been staged using independent neuropathological and neuroimaging modalities. The two schemes tie into the concept of pathological spread through corticofugal axonal transmission that stems from observation of oligodendrocyte pTDP-43 aggregates along with neuronal inclusions. Here, we aimed to assess evidence of transmission along axonal pathways by looking for pTDP-43 oligodendrocyte pathology in involved white matter tracts, and to present a first validation of the neuropathological staging scheme. pTDP-43 immunohistochemistry was performed in select white matter tracts and grey matter regions from the staging scheme in postmortem-confirmed ALS cases (N = 34). Double-labelling immunofluorescence was performed to confirm co-localisation of pTDP-43 immunoreactivity to oligodendrocytes. While pTDP-43 immunoreactive oligodendrocytes were frequent in the white matter under the motor and sensory cortices, similar assessment of the white matter along the corticospinal tract and in the corpus callosum and cingulum bundle of the same cases revealed no pTDP-43 pathology, questioning the involvement of oligodendrocytes in pathological propagation. The assessment of Betz cell loss revealed that the lack of deep white matter pTDP-43 oligodendrocyte pathology was not due to an absence of motor axons. Assessment of the propagation of pathology to different grey matter regions validated that all cases could be allocated to one of four neuropathological stages, although Stage 4 cases were found to differ significantly in age of onset (~10 years older) and disease duration (shorter duration than Stage 3 and similar to Stage 2). Four stages of ALS neuropathology can be consistently identified, although evidence of sequential clinical progression requires further assessment. As limited pTDP-43 oligodendrocyte pathology in deep corticospinal and other white matter tracts from the motor cortex was observed, the propagation of pathology between neurons may not involve oligodendrocytes and the interpretation of the changes observed on neuroimaging should be modified accordingly.Keywords
Funding Information
- National Health and Medical Research Council (1037746)
- National Health and Medical Research Council (1079679)
- Motor Neurone Disease Research Institute of Australia (ᅟ)
This publication has 26 references indexed in Scilit:
- The expanding syndrome of amyotrophic lateral sclerosis: a clinical and molecular odysseyJournal of Neurology, Neurosurgery & Psychiatry, 2015
- Neuroimaging in amyotrophic lateral sclerosis: insights into structural and functional changesThe Lancet Neurology, 2014
- Diffusion tensor imaging analysis of sequential spreading of disease in amyotrophic lateral sclerosis confirms patterns of TDP-43 pathologyBrain, 2014
- Advances in motor neurone diseaseJournal of the Royal Society of Medicine, 2014
- Amyotrophic lateral sclerosis—a model of corticofugal axonal spreadNature Reviews Neurology, 2013
- Stages of pTDP‐43 pathology in amyotrophic lateral sclerosisAnnals of Neurology, 2013
- The genetics and neuropathology of amyotrophic lateral sclerosisActa Neuropathologica, 2012
- Neuroimaging in Amyotrophic Lateral SclerosisBiomarkers in Medicine, 2012
- Molecular pathology and genetic advances in amyotrophic lateral sclerosis: an emerging molecular pathway and the significance of glial pathologyActa Neuropathologica, 2011
- Pathological TDP‐43 distinguishes sporadic amyotrophic lateral sclerosis from amyotrophic lateral sclerosis with SOD1 mutationsAnnals of Neurology, 2007